Century Therapeutics Inc
IPSC0.552USD
+0.020+3.78%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
47.55MMarket Cap
LossP/E TTM
Century Therapeutics Inc
0.552
+0.020+3.78%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q3
FY2020Q2
FY2020Q1
Total revenue
12667.72%109.16M
1457.09%4.17M
434.46%791.00K
678.79%771.00K
-50.29%855.00K
-48.56%268.00K
-93.35%148.00K
-92.91%99.00K
62.57%1.72M
--521.00K
--2.22M
--1.40M
--1.06M
----
----
----
----
----
----
----
Revenue
12667.72%109.16M
1457.09%4.17M
434.46%791.00K
678.79%771.00K
-50.29%855.00K
-48.56%268.00K
-93.35%148.00K
-92.91%99.00K
62.57%1.72M
--521.00K
--2.22M
--1.40M
--1.06M
----
----
----
----
----
----
----
Operating expenses
8.78%34.99M
20.22%37.13M
11.98%35.58M
14.76%35.53M
-4.84%32.16M
-8.70%30.89M
-6.44%31.77M
-5.47%30.96M
18.62%33.80M
20.93%33.83M
31.50%33.96M
42.25%32.75M
57.76%28.49M
--27.97M
96.69%25.83M
113.28%23.02M
80.75%18.06M
--13.13M
--10.79M
--9.99M
R&D expenses
13.49%26.58M
31.75%29.38M
19.48%27.23M
19.77%27.22M
-5.94%23.42M
-12.86%22.30M
-12.01%22.79M
-7.21%22.73M
17.47%24.90M
17.38%25.59M
32.50%25.90M
29.37%24.49M
37.87%21.20M
--21.80M
80.77%19.55M
123.16%18.93M
93.55%15.37M
--10.81M
--8.48M
--7.94M
Depreciation, depletion, and amortization
-0.15%3.22M
-6.59%3.32M
-1.55%3.30M
5.81%3.46M
8.84%3.23M
22.19%3.55M
17.46%3.35M
87.61%3.27M
139.81%2.96M
157.71%2.91M
154.42%2.85M
72.33%1.74M
55.86%1.24M
--1.13M
164.39%1.12M
258.87%1.01M
296.50%793.00K
--424.00K
--282.00K
--200.00K
Operating profit
336.92%74.18M
-7.64%-32.96M
-10.00%-34.79M
-12.63%-34.76M
2.41%-31.31M
8.07%-30.62M
0.35%-31.63M
1.58%-30.86M
-16.93%-32.08M
-19.06%-33.31M
-22.89%-31.74M
-36.18%-31.35M
-51.90%-27.44M
---27.97M
-96.69%-25.83M
-113.28%-23.02M
-80.75%-18.06M
---13.13M
---10.79M
---9.99M
Net non-operating interest income (expenses)
Non-operating interest income
-25.18%2.42M
-17.92%2.88M
-5.19%3.31M
17.14%3.58M
23.41%3.24M
--3.51M
--3.49M
--3.06M
--2.62M
----
----
----
----
----
----
----
----
----
----
----
Non-operating interest expense
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-58.79%136.00K
28.66%404.00K
28.66%413.00K
15.84%373.00K
3.77%330.00K
0.00%314.00K
--321.00K
445.76%322.00K
--318.00K
--314.00K
--59.00K
--0.00
--0.00
Gains from sale of securities
----
----
----
----
----
----
----
----
----
1346.85%2.07M
890.71%1.39M
977.27%711.00K
803.57%253.00K
--143.00K
16.67%140.00K
-69.30%66.00K
-91.25%28.00K
--120.00K
--215.00K
--320.00K
Special income (expenses)
----
67.08%-4.33M
100.00%0.00
100.00%0.00
----
---13.14M
---4.00M
---4.22M
100.00%0.00
--0.00
--0.00
--0.00
---10.00M
--0.00
--0.00
100.00%0.00
----
--0.00
---4.72M
----
Other non-operating income (expenses)
-445.45%-38.00K
806.67%106.00K
1983.33%250.00K
93.55%-12.00K
105.67%11.00K
---15.00K
--12.00K
---186.00K
---194.00K
----
----
----
----
----
----
----
----
----
----
----
Income before tax
372.83%76.56M
14.83%-34.30M
2.78%-31.23M
3.57%-31.18M
6.64%-28.06M
-27.23%-40.27M
-4.57%-32.13M
-4.43%-32.34M
19.84%-30.06M
-12.43%-31.65M
-18.13%-30.72M
-33.07%-30.97M
-104.37%-37.50M
---28.15M
-99.00%-26.01M
-52.10%-23.27M
-89.68%-18.35M
---13.07M
---15.30M
---9.67M
Income tax
-100.00%0.00
304.37%1.78M
-101.35%-8.00K
-97.68%22.00K
-99.92%1.00K
-2815.63%-869.00K
2268.00%592.00K
5177.78%950.00K
7450.00%1.21M
-25.58%32.00K
--25.00K
--18.00K
--16.00K
--43.00K
----
----
----
----
----
----
Income after tax
372.82%76.56M
8.44%-36.07M
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-24.35%-39.40M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-12.37%-31.68M
-18.22%-30.75M
-33.15%-30.99M
-104.45%-37.51M
---28.19M
-99.00%-26.01M
-52.10%-23.27M
-89.68%-18.35M
---13.07M
---15.30M
---9.67M
Net income from continuous operations
372.82%76.56M
8.44%-36.07M
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-24.35%-39.40M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-12.37%-31.68M
-18.22%-30.75M
-33.15%-30.99M
-104.45%-37.51M
---28.19M
-99.00%-26.01M
-52.10%-23.27M
-89.68%-18.35M
---13.07M
---15.30M
---9.67M
Net income attributable to controlling interests
372.82%76.56M
8.44%-36.07M
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-24.35%-39.40M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-12.37%-31.68M
-18.22%-30.75M
-33.15%-30.99M
-104.45%-37.51M
---28.19M
-99.00%-26.01M
-52.10%-23.27M
-89.68%-18.35M
---13.07M
---15.30M
---9.67M
Net income attributable to common shareholders
372.82%76.56M
8.44%-36.07M
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-24.35%-39.40M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-12.37%-31.68M
-18.22%-30.75M
-33.15%-30.99M
-104.45%-37.51M
---28.19M
-99.00%-26.01M
-52.10%-23.27M
-89.68%-18.35M
---13.07M
---15.30M
---9.67M
Basic earnings per share
297.58%0.89
35.69%-0.42
33.02%-0.37
32.34%-0.38
15.55%-0.45
-20.85%-0.66
-3.77%-0.55
-4.59%-0.56
18.88%-0.53
-6.11%-0.54
-11.09%-0.53
72.20%-0.54
72.49%-0.66
---0.51
72.67%-0.48
5.52%-1.93
-84.86%-2.39
---1.75
---2.05
---1.29
Diluted earnings per share
297.40%0.89
35.69%-0.42
33.02%-0.37
32.34%-0.38
15.55%-0.45
-20.85%-0.66
-3.77%-0.55
-4.59%-0.56
18.88%-0.53
-6.11%-0.54
-11.09%-0.53
72.20%-0.54
72.49%-0.66
---0.51
72.67%-0.48
5.52%-1.93
-84.86%-2.39
---1.75
---2.05
---1.29
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
